Alliance Pharma plc Share Price

Equities

APH

GB0031030819

Pharmaceuticals

Market Closed - London S.E. 09:05:02 17/07/2024 pm IST 5-day change 1st Jan Change
35.5 GBX -0.56% Intraday chart for Alliance Pharma plc -0.70% -12.35%

Financials

Sales 2024 * 191M 249M 20.77B Sales 2025 * 205M 266M 22.22B Capitalization 192M 250M 20.84B
Net income 2024 * 15M 19.51M 1.63B Net income 2025 * 20M 26.01M 2.17B EV / Sales 2024 * 1.4 x
Net Debt 2024 * 75.3M 97.94M 8.18B Net Debt 2025 * 48.34M 62.87M 5.25B EV / Sales 2025 * 1.17 x
P/E ratio 2024 *
12.4 x
P/E ratio 2025 *
9.57 x
Employees 292
Yield 2024 *
1.25%
Yield 2025 *
1.33%
Free-Float 87.8%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.56%
1 week-0.70%
Current month-8.74%
1 month+8.07%
3 months-3.01%
6 months-4.70%
Current year-12.35%
More quotes
1 week
34.80
Extreme 34.8
38.35
1 month
32.00
Extreme 32
43.10
Current year
24.55
Extreme 24.55
46.00
1 year
24.55
Extreme 24.55
52.80
3 years
24.55
Extreme 24.55
123.00
5 years
24.55
Extreme 24.55
123.00
10 years
24.55
Extreme 24.55
123.00
More quotes
Managers TitleAgeSince
Director of Finance/CFO 58 28/15/28
Chief Operating Officer - 01/23/01
Chief Operating Officer 56 01/13/01
Members of the board TitleAgeSince
Director/Board Member 55 01/23/01
Director/Board Member 58 01/19/01
Director/Board Member 57 07/11
More insiders
Date Price Change Volume
17/24/17 35.5 -0.56% 526 298
16/24/16 35.7 -1.38% 1,441,201
15/24/15 36.2 -3.47% 634,950
12/24/12 37.5 +2.74% 1,685,055
11/24/11 36.5 +2.10% 1,556,649

Delayed Quote London S.E., July 17, 2024 at 09:05 pm IST

More quotes
Alliance Pharma plc is a United Kingdom-based international consumer healthcare company. The principal activity of the Company is to act as a holding company. The principal activity of the Company is the acquisition, marketing and distribution of consumer healthcare and pharmaceutical products. Its segments include Consumer Healthcare brands and Prescription Medicines. Its Consumer Healthcare brands include the Kelo-Cote franchise, Amberen, Nizoral, MacuShield, Aloclair, Vamousse, and other consumer healthcare brands. Its Prescription Medicines include Hydromol, Flamma Franchise, Forceval and other prescription medicines. Its products include Aloclair Plus Gel, Aloclair Plus Spray, Aloclair Plus Mouthwash, Anbesol Adult Strength Gel, Anbesol Teething Gel, Anbesol Liquid, Atopiclair Cream, and Atopiclair Lotion. It holds marketing rights to around 80 consumer healthcare brands and prescription medicines, which are sold worldwide in more than 100 countries.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
0.357 GBP
Average target price
0.6243 GBP
Spread / Average Target
+74.87%
Consensus

Quarterly revenue - Rate of surprise